Pear Therapeutics Announces First Participant Enrolled in National Institutes of Health Clinical Trial Investigating Combinations of Pharmacological and Behavioral Interventions to Treat Opioid Use Disorder View more
Miromatrix Awarded $1.9 Million NIH Grant to Advance the Development of a Bioengineered Liver View more